Giles Platford | Takeda Pharmaceuticals

Giles Platford is president of the Plasma-Derived Therapies Business Unit, which researches and delivers critical life-transforming medicines used to treat a variety of rare and complex chronic diseases.

Giles also serves as the current global chair of the board for the Plasma Protein Therapeutics Association, which represents the private sector manufacturers of plasma protein therapies.

Giles joined Takeda in 2009 as general manager of Brazil, and later took on the role of area head for Middle East, Turkey & Africa. He then joined the Takeda Executive Team in 2014 as president of Emerging Markets. In 2017, he became president of Europe & Canada, where he also represented Takeda as a board member of the European Federation of Pharmaceutical Industries and Associations.

Prior to joining Takeda, Giles spent eight years in Asia Pacific, where he held a number of roles of increasing responsibility in Business Development, Commercial and General Management.

Giles holds a Bachelor of Arts degree in business and marketing management from Oxford Brookes University, UK, and is currently based in Cambridge, Massachusetts.